Quantitative Sensory Testing (QST) as a tool to assess and quantify thoracic pain in patients with chronic interstitial lung disease (ILD)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00022978

Enrollment

Registered

2020-08-31

Start date

2017-04-11

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J84.9 R07.4

Interventions

Group 1: Evaluation of thoracic pain and performance of quantitative sensory testing on the day of recruitment. Furthermore, recording of the patients demographic and clinical data.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Outpatients and inpatients of the Ruhrlandklinik; Interstitial lung disease diagnosed according to ATS/ERS criteria 2002 or 2013 (3): IPF, NSIP, COP, EAA, DIP, RBILD, PAP

Exclusion criteria

Exclusion criteria: Incompletely documented history or unclassifiable ILD

Design outcomes

Primary

Measure	Time frame
Comparison of the pain sensitivity of patients with interstitial lung diseases with and without thoracic pain measured on the day of patient inclusion using quantitative sensory testing.	—

Secondary

Measure	Time frame
Comparison of clinical data between patients with and without thoracic pain.	—

Countries

Germany

Contacts

Public ContactManuela Scherer

Ruhrlandklinik Essen - Universitätsmedizin Essen

manuela.scherer@rlk.uk-essen.de02014334528

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 9, 2026